86
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Lateral Ventricular Meningiomas: Clinical Features, Radiological Findings and Long-Term Outcomes

, , , , , & ORCID Icon show all
Pages 6089-6099 | Published online: 04 Aug 2021

References

  • Claus E, Bondy M, Schildkraut J, Wiemels J, Wrensch M, Black P. Epidemiology of intracranial meningioma. Neurosurgery. 2005;57(6):1088–1095. doi:10.1227/01.NEU.0000188281.91351.B916331155
  • Chen W, Magill S, Englot D, et al. Factors associated with pre- and postoperative seizures in 1033 patients undergoing supratentorial meningioma resection. Neurosurgery. 2017;81(2):297–306. doi:10.1093/neuros/nyx00128327947
  • Pereira BJA, de Almeida AN, Paiva WS, de Aguiar PH, Teixeira MJ, Marie SK. Natural history of intraventricular meningiomas: systematic review. Neurosurg Rev. 2020;43(2):513–523. doi:10.1007/s10143-018-1019-030112665
  • Menon G, Nair S, Sudhir J, Rao R, Easwer H, Krishnakumar K. Meningiomas of the lateral ventricle – a report of 15 cases. Br J Neurosurg. 2009;23(3):297–303. doi:10.1080/0268869090272186219533463
  • Lyngdoh B, Giri P, Behari S, Banerji D, Chhabra D, Jain V. Intraventricular meningiomas: a surgical challenge. J Clin Neurosci. 2007;14(5):442–448.17350844
  • Criscuolo G, Symon L. Intraventricular meningioma. A review of 10 cases of the National Hospital, Queen Square (1974–1985) with reference to the literature. Acta Neurochir. 1986;83:83–91.3492867
  • Li Z, Li H, Jiao Y, et al. Clinical features and long-term outcomes of pediatric intraventricular meningiomas: data from a single neurosurgical center. Neurosurg Rev. 2018;41(2):525–530. doi:10.1007/s10143-017-0884-228766173
  • Civit T, Taillandier L, Baylac F. Chordoid meningioma. J Neurosurg. 1998;89(4):686–687.
  • Baumgartner J, Sorenson J. Meningioma in the pediatric population. J Neurooncol. 1996;29(3):223–228.8858528
  • Bhatoe H, Singh P, Dutta V. Intraventricular meningiomas: a clinicopathological study and review. Neurosurg Focus. 2006;20(3):E9.
  • Magill ST, Young JS, Chae R, Aghi MK, Theodosopoulos PV, McDermott MW. Relationship between tumor location, size, and WHO grade in meningioma. Neurosurg Focus. 2018;44(4):E4. doi:10.3171/2018.1.FOCUS17752
  • Kshettry VR, Ostrom QT, Kruchko C, Al-Mefty O, Barnett GH, Barnholtz-Sloan JS. Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States. Neuro Oncol. 2015;17(8):1166–1173. doi:10.1093/neuonc/nov06926008603
  • Go K, Kamman R, Wilmink J, Mooyaart E. A study on peritumoral brain edema around meningiomas by MRI and contrast CT. J Acta Neurochirurgica Supplementa. 1994;60:365–368.
  • Go K, Wilmink J, Molenaar WJN. Peritumoral brain edema associated with meningiomas. Neurosurgery. 1988;23(2):175–179.3185876
  • Nakano T, Asano K, Miura H, Itoh S, Suzuki S. Meningiomas with brain edema: radiological characteristics on MRI and review of the literature. Clin Imaging. 2002;26(4):243–249.12140153
  • Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet. 2004;363(9420):1535–1543. doi:10.1016/S0140-6736(04)16153-915135603
  • Kim E, Kim S, Kim H, Jeon P, Kim K, Byun H. Intraventricular meningiomas: radiological findings and clinical features in 12 patients. Clin Imaging. 2009;33(3):175–180.19411021
  • Lin B, Chou K, Kao H, et al. Correlation between magnetic resonance imaging grading and pathological grading in meningioma. J Neurosurg. 2014;121(5):1201–1208.25148010
  • Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handa J. Meningioma: proliferating potential and clinicoradiological features. Neurosurgery. 1995;37(6):1049–1055.8584144
  • Takeguchi T, Miki H, Shimizu T, et al. Prediction of tumor-brain adhesion in intracranial meningiomas by MR imaging and DSA. Magn Reson Med Sci. 2003;2(4):171–179.16222111
  • Ye W, Ding-Zhong T, Xiao-Sheng Y, Ren-Ya Z, Yi L. Factors related to the post-operative recurrence of atypical meningiomas. Front Oncol. 2020;10:503.32351890
  • Aguiar P, Tsanaclis A, Tella O, Plese J. Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics. Neurosurg Rev. 2003;26(3):221–228.12690530
  • Kudryavtsev G, Kudryavtseva L, Mikhaleva L, Solovieva N, Babichenko I. [Immunohistochemical study of Ki-67, p53 and Notch1 expressions in prostate cancer of different grades]. Arkhiv Patologii. 2020;82(5):42–49. Russian.33054031
  • Kasuya H, Kubo O, Tanaka M, Amano K, Kato K, Hori T. Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev. 2006;29(4):293–296;discussion 296–297.
  • Kim Y, Ketter R, Steudel W, Feiden W. Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas. Am J Clin Pathol. 2007;128(1):118–125.17580279
  • Ros-Sanjuan A, Iglesias-Moroño S, Carrasco-Brenes A, Bautista-Ojeda D, Arraez-Sanchez M. Atypical meningiomas: histologic and clinical factors associated with recurrence. World Neurosurg. 2019;125:e248–e256.30684705
  • Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):22–39. doi:10.1136/jnnp.20.1.2213406590
  • Schwartz T, McDermott M. The Simpson grade: abandon the scale but preserve the message. J Neurosurg. 2020;1:1–8.
  • Voß K, Spille D, Sauerland C, et al. The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value? J Neurooncol. 2017;133(3):641–651.28527009
  • Oya S, Kawai K, Nakatomi H, Saito N. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO grade I meningiomas. J Neurosurg. 2012;117(1):121–128.22559847
  • Unterberger A, Nguyen T, Duong C, Kondajji A, Kulinich D, Yang I. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas. J Neurooncol. 2021;152(2):205–216. doi:10.1007/s11060-020-03674-733635510
  • Chen W, Magill S, Wu A, et al. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy. J Neurosurg. 2018;130(2):443–450.29624151
  • Aghi M, Carter B, Cosgrove G, et al. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery. 2009;64(1):56–60; discussion 60.
  • Zhi M, Girvigian M, Miller M, et al. Long-term outcomes of newly diagnosed resected atypical meningiomas and the role of adjuvant radiotherapy. World Neurosurg. 2019;122:e1153–e1161.30447464
  • Cain S, Smoll N, Van Heerden J, Tsui A, Drummond K. Atypical and malignant meningiomas: considerations for treatment and efficacy of radiotherapy. J Clin Neurosci. 2015;22(11):1742–1748.26213286
  • Bagshaw H, Burt L, Jensen R, et al. Adjuvant radiotherapy for atypical meningiomas. J Neurosurg. 2017;126(6):1822–1828.27611201
  • Masalha W, Heiland D, Franco P, et al. Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy. J Neurooncol. 2018;136(1):147–154.29081038
  • Hammouche S, Clark S, Wong A, Eldridge P, Farah J. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment. Acta Neurochir. 2014;156(8):1475–1481.24965072